BIOLASE BIOL Stock
BIOLASE Price Chart
BIOLASE BIOL Financial and Trading Overview
| BIOLASE stock price | 0.01 USD |
| Previous Close | 0.07 USD |
| Open | 0.07 USD |
| Bid | 0 USD x 1300 |
| Ask | 0 USD x 800 |
| Day's Range | 0.07 - 0.08 USD |
| 52 Week Range | 0.06 - 5.94 USD |
| Volume | 8.72M USD |
| Avg. Volume | 4.37M USD |
| Market Cap | 2.47M USD |
| Beta (5Y Monthly) | 1.375704 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | June 24, 2005 |
| 1y Target Est | 2.7 USD |
BIOL Valuation Measures
| Enterprise Value | 11.76M USD |
| Trailing P/E | N/A |
| Forward P/E | -3.9500003 |
| PEG Ratio (5 yr expected) | -0.02 |
| Price/Sales (ttm) | 0.050711606 |
| Price/Book (mrq) | 0.2548387 |
| Enterprise Value/Revenue | 0.241 |
| Enterprise Value/EBITDA | -0.454 |
Trading Information
BIOLASE Stock Price History
| Beta (5Y Monthly) | 1.375704 |
| 52-Week Change | -98.24% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 5.94 USD |
| 52 Week Low | 0.06 USD |
| 50-Day Moving Average | 0.18 USD |
| 200-Day Moving Average | 1.01 USD |
BIOL Share Statistics
| Avg. Volume (3 month) | 4.37M USD |
| Avg. Daily Volume (10-Days) | 7.51M USD |
| Shares Outstanding | 31.3M |
| Float | 22.41M |
| Short Ratio | 0.34 |
| % Held by Insiders | 15.47% |
| % Held by Institutions | 12.97% |
| Shares Short | 2.09M |
| Short % of Float | 6.70% |
| Short % of Shares Outstanding | 6.69% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:25 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -60.92% |
| Operating Margin (ttm) | -54.18% |
| Gross Margin | 29.77% |
| EBITDA Margin | -53.10% |
Management Effectiveness
| Return on Assets (ttm) | -35.82% |
| Return on Equity (ttm) | -206.59% |
Income Statement
| Revenue (ttm) | 48.76M USD |
| Revenue Per Share (ttm) | 3.59 USD |
| Quarterly Revenue Growth (yoy) | 3.00% |
| Gross Profit (ttm) | N/A |
| EBITDA | -25894000 USD |
| Net Income Avi to Common (ttm) | -29707000 USD |
| Diluted EPS (ttm) | -3.58 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 6.53M USD |
| Total Cash Per Share (mrq) | 0.24 USD |
| Total Debt (mrq) | 16.1M USD |
| Total Debt/Equity (mrq) | 197.34 USD |
| Current Ratio (mrq) | 1.682 |
| Book Value Per Share (mrq) | 0.31 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -24398000 USD |
| Levered Free Cash Flow (ttm) | -16789500 USD |
Profile of BIOLASE
| Country | United States |
| State | CA |
| City | Foothill Ranch |
| Address | 27042 Towne Centre Drive |
| ZIP | 92610-2811 |
| Phone | 949 361 1200 |
| Website | https://www.biolase.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 188 |
BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; diode soft-tissue laser systems for soft tissue, hygiene, therapy pain relief, teeth whitening, and cosmetic procedures; and Epic Hygiene laser to manage non-surgical periodontitis and enhance clinical production. It also manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces; and sells teeth whitening gel kits. The company sells its products through its field sales force and distributor network. The company was formerly known as BIOLASE Technology, Inc. and changed its name to BIOLASE, Inc. in 2012. BIOLASE, Inc. was founded in 1984 and is headquartered in Foothill Ranch, California.
Q&A For BIOLASE Stock
What is a current BIOL stock price?
BIOLASE BIOL stock price today per share is 0.01 USD.
How to purchase BIOLASE stock?
You can buy BIOL shares on the OTC Markets OTCQB exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for BIOLASE?
The stock symbol or ticker of BIOLASE is BIOL.
Which industry does the BIOLASE company belong to?
The BIOLASE industry is Medical Devices.
How many shares does BIOLASE have in circulation?
The max supply of BIOLASE shares is 36.6M.
What is BIOLASE Price to Earnings Ratio (PE Ratio)?
BIOLASE PE Ratio is 0.00000000 now.
What was BIOLASE earnings per share over the trailing 12 months (TTM)?
BIOLASE EPS is 0 USD over the trailing 12 months.
Which sector does the BIOLASE company belong to?
The BIOLASE sector is Healthcare.
BIOLASE BIOL included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16550.61 USD — |
-5.97
|
8.29B USD — | 16533.04 USD — | 16889.34 USD — | — - | 8.29B USD — |
| NASDAQ Composite Total Return I XCMP | 20257.83 USD — |
-5.96
|
— — | 20236.33 USD — | 20672.41 USD — | — - | — — |
| NASDAQ Capital Market Composite RCMP | 96.46 USD — |
-4.76
|
— — | 95.94 USD — | 97.68 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 920.53 USD — |
-2.33
|
— — | 917.85 USD — | 930.28 USD — | — - | — — |
- {{ link.label }} {{link}}